FI880959A - Anvaendning av aktiverat rnas l som markeringsaemne i virusinfektioner. - Google Patents

Anvaendning av aktiverat rnas l som markeringsaemne i virusinfektioner. Download PDF

Info

Publication number
FI880959A
FI880959A FI880959A FI880959A FI880959A FI 880959 A FI880959 A FI 880959A FI 880959 A FI880959 A FI 880959A FI 880959 A FI880959 A FI 880959A FI 880959 A FI880959 A FI 880959A
Authority
FI
Finland
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
FI880959A
Other languages
English (en)
Other versions
FI880959A0 (fi
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of FI880959A0 publication Critical patent/FI880959A0/fi
Publication of FI880959A publication Critical patent/FI880959A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI880959A 1987-03-03 1988-03-02 Anvaendning av aktiverat rnas l som markeringsaemne i virusinfektioner. FI880959A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (2)

Publication Number Publication Date
FI880959A0 FI880959A0 (fi) 1988-03-02
FI880959A true FI880959A (fi) 1988-09-04

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880959A FI880959A (fi) 1987-03-03 1988-03-02 Anvaendning av aktiverat rnas l som markeringsaemne i virusinfektioner.

Country Status (20)

Country Link
EP (1) EP0285263B1 (fi)
JP (1) JPH0675520B2 (fi)
KR (1) KR880011593A (fi)
AT (1) ATE107964T1 (fi)
AU (1) AU618525B2 (fi)
CA (1) CA1337278C (fi)
DE (1) DE3850428T2 (fi)
DK (1) DK112888A (fi)
ES (1) ES2058252T3 (fi)
FI (1) FI880959A (fi)
IE (1) IE66831B1 (fi)
IL (1) IL85576A0 (fi)
MX (1) MX173802B (fi)
NO (1) NO880934L (fi)
NZ (1) NZ223721A (fi)
OA (1) OA08720A (fi)
PH (1) PH30882A (fi)
PT (1) PT86878B (fi)
RU (1) RU2049336C1 (fi)
ZA (1) ZA881471B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
EP0350151B1 (en) * 1988-07-07 1994-03-30 Hem Pharmaceuticals Corp. Diagnosing and treating chronic fatigue syndrome
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
US11859234B2 (en) 2016-05-06 2024-01-02 The Trustees Of Princeton University Method of monitoring RNase L activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
CA1337278C (en) 1995-10-10
NO880934D0 (no) 1988-03-02
ES2058252T3 (es) 1994-11-01
FI880959A0 (fi) 1988-03-02
DE3850428T2 (de) 1994-11-24
DK112888A (da) 1988-09-04
AU1256388A (en) 1988-09-01
PT86878B (pt) 1992-05-29
DK112888D0 (da) 1988-03-02
AU618525B2 (en) 1992-01-02
OA08720A (en) 1989-03-31
IE66831B1 (en) 1996-02-07
PH30882A (en) 1997-12-23
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
EP0285263B1 (en) 1994-06-29
JPS63309200A (ja) 1988-12-16
ZA881471B (en) 1988-12-28
EP0285263A3 (en) 1990-04-18
IE880587L (en) 1988-09-03
IL85576A0 (en) 1988-08-31
NZ223721A (en) 1991-02-26
RU2049336C1 (ru) 1995-11-27
ATE107964T1 (de) 1994-07-15
NO880934L (no) 1988-09-05
EP0285263A2 (en) 1988-10-05
PT86878A (pt) 1988-04-01
JPH0675520B2 (ja) 1994-09-28
DE3850428D1 (de) 1994-08-04

Similar Documents

Publication Publication Date Title
WO1994023041A3 (en) Method for selective inactivation of viral replication
FI880959A0 (fi) Anvaendning av aktiverat rnas l som markeringsaemne i virusinfektioner.
SE9103183L (sv) Virus-antikroppskomplex
WO2003079757A3 (en) Hiv therapeutic
WO1993017651A3 (de) Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
FI883763A0 (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
TR199901530T2 (xx) HIV ve kanser tedavisi.
SE8601435D0 (sv) Aktivt pansar
CA2478527A1 (en) Arrangement for supporting a mortar shell into barrel of weapon and a method for attaching a support member to a mortar shell
ES8708243A1 (es) Un procedimiento para preparar un copolimero de bloques de un hidrocarburo monoalquenilaromatico polimerizado y un hidrocarburo dienico conjugado polimerizado
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
Maldonado Olutec motion verbs: Grammaticalization under Mayan contact
DE60128565D1 (en) Polycyclische xanthone als antibiotika
ES8400821A1 (es) Granada de fusil.
AR247215A1 (es) Un procedimiento para producir un antibiotico antifungico y antiviral, n-acetilbenanomicina b.
NO985110L (no) Eksplosivformuleringer
chromosome Y-Chromosom et al. Blastomyzet m. yellow I n 1.(Farbe) Gelb nt. 2. Ei
ES2007094A6 (es) Procedimiento para la preparacion de 3 -c- ciano-2,3 -didesoxinucleosido.
SE8702004L (sv) Rotationsprojektil med ett ihaligt nosparti
ES2093801T3 (es) Propenales sustituidos con un ciclo ditiano y procedimiento de preparacion de estos propenales.
ES2007987A6 (es) Procedimiento de obtencion de un derivado de guanina.
ES2007988A6 (es) Procedimiento de obtencion de un derivado de guanina.
MX9300301A (es) Estructura ligera modular aerodinamica para usos multiples.
AR247287A1 (es) Encendedor de gas

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: HEM RESEARCH, INC.